Cardiovascular Systems to Present at William Blair 3rd Annual Emerging Growth Stock Conference on Tuesday, Oct. 6

Live Webcast Available at 8:45 a.m. EST

• Press Release
• Source: Cardiovascular Systems, Inc.
• On 11:30 am EDT, Wednesday September 30, 2009

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (Nasdaq: CSII - News), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at the William Blair 3rd Annual Emerging Growth Stock Conference on October 6 at the Waldorf-Astoria Hotel in New York. President and Chief Executive Officer David L. Martin and Chief Financial Officer Laurence L. Betterley will provide an overview of the company and its strategies for growth.

Related Quotes

Symbol	Price	Change
CSII	5.05	+0.06

{"s" : "csii","k" : "c10,l10,p20,t10","o" : "","j" : ""}

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. is a medical device company focused on developing and commercializing interventional treatment systems for vascular disease. The company's Diamondback 360^® PAD System is capable of treating a broad range of plaque types both above and below the knee, including calcified vessel lesions, and addresses many of the limitations associated with existing treatment alternatives. In August 2007, the U.S. FDA granted 510(k) clearance for the use of the Diamondback 360° as a therapy for PAD (peripheral arterial disease), and CSI commenced a U.S. product launch in September 2007. The Diamondback 360° system has been adopted by nearly 600 hospitals across the United States. For more information visit the company's Web site at www.csi360.com.

Cardiovascular Systems, Inc.:
Investor Relations
651-259-2800
or
Padilla Speer Beardsley:
Nancy A. Johnson
612-455-1745
njohnson@psbpr.com